These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29135689)

  • 21. Ectopic lipid storage and insulin resistance: a harmful relationship.
    Borén J; Taskinen MR; Olofsson SO; Levin M
    J Intern Med; 2013 Jul; 274(1):25-40. PubMed ID: 23551521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes.
    Ravikumar B; Carey PE; Snaar JE; Deelchand DK; Cook DB; Neely RD; English PT; Firbank MJ; Morris PG; Taylor R
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E789-97. PubMed ID: 15572652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability.
    Oakes ND; Thalén PG; Jacinto SM; Ljung B
    Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization.
    Kotani K; Peroni OD; Minokoshi Y; Boss O; Kahn BB
    J Clin Invest; 2004 Dec; 114(11):1666-75. PubMed ID: 15578099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics.
    Krag MB; Gormsen LC; Guo Z; Christiansen JS; Jensen MD; Nielsen S; Jørgensen JO
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E920-7. PubMed ID: 17132823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
    Vaziri ND; Liang K; Azad H
    J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma lipoprotein metabolism in lean and in fat chickens produced by divergent selection for plasma very low density lipoprotein concentration.
    Griffin H; Acamovic F; Guo K; Peddie J
    J Lipid Res; 1989 Aug; 30(8):1243-50. PubMed ID: 2769076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal muscle triglycerides: an aspect of regional adiposity and insulin resistance.
    Kelley DE
    Ann N Y Acad Sci; 2002 Jun; 967():135-45. PubMed ID: 12079843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating very-low-density lipoprotein characteristics resulting from fatty liver in an insulin resistance rat model.
    Zago V; Lucero D; Macri EV; Cacciagiú L; Gamba CA; Miksztowicz V; Berg G; Wikinski R; Friedman S; Schreier L
    Ann Nutr Metab; 2010; 56(3):198-206. PubMed ID: 20203480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes.
    Vergès B
    Atherosclerosis; 2010 Aug; 211(2):353-60. PubMed ID: 20189175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of body composition on very-low-density lipoprotein-triglycerides kinetics.
    Gormsen LC; Nellemann B; Sørensen LP; Jensen MD; Christiansen JS; Nielsen S
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E165-73. PubMed ID: 18984851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes.
    Lewis GF; Carpentier A; Adeli K; Giacca A
    Endocr Rev; 2002 Apr; 23(2):201-29. PubMed ID: 11943743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overproduction of large VLDL particles is driven by increased liver fat content in man.
    Adiels M; Taskinen MR; Packard C; Caslake MJ; Soro-Paavonen A; Westerbacka J; Vehkavaara S; Häkkinen A; Olofsson SO; Yki-Järvinen H; Borén J
    Diabetologia; 2006 Apr; 49(4):755-65. PubMed ID: 16463046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MECHANISMS IN ENDOCRINOLOGY: Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander?
    Brøns C; Grunnet LG
    Eur J Endocrinol; 2017 Feb; 176(2):R67-R78. PubMed ID: 27913612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Troglitazone action is independent of adipose tissue.
    Burant CF; Sreenan S; Hirano K; Tai TA; Lohmiller J; Lukens J; Davidson NO; Ross S; Graves RA
    J Clin Invest; 1997 Dec; 100(11):2900-8. PubMed ID: 9389757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes.
    Goodpaster BH; Wolf D
    Pediatr Diabetes; 2004 Dec; 5(4):219-26. PubMed ID: 15601366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic fat content is a determinant of postprandial triglyceride levels in type 2 diabetes mellitus patients with normal fasting triglyceride.
    Nimitphong H; Phongkitkarun S; Rattarasarn C; Kongsooksai A; Chanprasertyothin S; Bunnag PA; Puavilai G
    Metabolism; 2008 May; 57(5):644-9. PubMed ID: 18442627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians.
    Abbott WG; Swinburn B; Ruotolo G; Hara H; Patti L; Harper I; Grundy SM; Howard BV
    J Clin Invest; 1990 Aug; 86(2):642-50. PubMed ID: 2200808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice.
    Geerling JJ; Boon MR; van der Zon GC; van den Berg SA; van den Hoek AM; Lombès M; Princen HM; Havekes LM; Rensen PC; Guigas B
    Diabetes; 2014 Mar; 63(3):880-91. PubMed ID: 24270984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of gemfibrozil administration on very low density lipoprotein receptor mRNA levels in rabbits.
    Matsuoka N; Jingami H; Masuzaki H; Mizuno M; Nakaishi S; Suga J; Tanaka T; Yamamoto T; Nakao K
    Atherosclerosis; 1996 Oct; 126(2):221-6. PubMed ID: 8902147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.